Savior Lifetec Corporation announced on November 27, 2014 that the Meropenem Active Pharmaceutical Ingredient (API) Manufacturing Facility in Tainan, Taiwan was deemed as complying with the Pharmaceutical Inspection Convention/Co-operation Scheme Guide to Good Manufacturing Practice (PIC/S GMP) guidelines for medicinal products. The inspection by the Taiwan Ministry of Health and Welfare was completed during the period of July 21-23, 2014.